Although GNAI2 has been linked to resistance in trastuzumab-treated breast cancer [62], no previous studies have addressed the association between GNAI gene expression and chemoresistance in COAD, highlighting the novelty of this observation and its therapeutic relevance. The gene discussed is GNAI2; the disease is breast cancer.